PRESCRIBING · PART D · 2024
Total Rx claims
457
Beneficiaries
—
Total drug cost
$564K
Distinct drugs
19
Brand share
57.5%
Top prescribed drugs
Dolutegravir Sodium65 claims
Bictegrav/Emtricit/Tenofov Ala56 claims
Emtricitabine/Tenofov Alafenam51 claims
Gabapentin34 claims
Atorvastatin Calcium30 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
74.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
REFERRAL NETWORK
Where Jehan Budak's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF WASHINGTON | 12 | 58 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE